|
|
Chief Medical Officer, Vice President of Clinical Development and Research
Agile Therapeutics
Princeton, NJ
mfoegh@agiletherapeutics.com
http://www.agiletherapeutics.com
Cambridge Who’s Who® Expert Since : January 27 2009
Cambridge Who’s Who® Member Since : November 22 2005
|
|
|
Industry:
Healthcare
Field:
Biomedical Drug Development
Area(s) of Expertise:
Employment History:
Published Works:
Public Speaking Experience:
Why
F
is an Expert:
I consider myself to be an expert on women’s health and transportation
Best Advice:
Passionate about:
I’m very passionate about health issues and getting treatment to patients in need.
Biography Excerpt:
With the transient nature of the healthcare industry, it seems as though every month ushers in a host of new studies, trials and drugs to refute the claims of those that preceded them, leaving consumers perplexed as to which products they should trust to treat or cure their ailments. Dr. Marie Foegh has spent more than 20 years assisting in the strategic development of pharmaceutical products and acquiring their approval from regulatory compliance agencies. She recently joined Agile Therapeutics as its chief medical officer and vice president of clinical development, roles that she is well-qualified to assume due to her prior experience with other pharmaceutical companies.
|
|
|
Interview Excerpt
|
|
|
|
Cambridge Who's Who:
What is the most significant issue facing your profession today?
DR.
MARIE
FOEGH
D.SC.: The most significant issue facing my profession is [the lack of] investments in novel ideas.
And what specific steps have you taken toward achieving these goals?
We have been marketing ourselves and showing what results we have, presenting ourselves to seek out investors.
What are your short-term and long-term career goals?
It’s a very difficult financial market at the moment. My short-term goal is to get enough venture capital interest for a larger study.
|
|
|
|
|
|
|
|
|
|
|
|
For more information about
Dr.
Marie
Foegh
D.Sc., visit her Cambridge Cambridge Who’s Who® profile at
|
|
|